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The glutamatergic system has been implicated in the pathophysiology of depression and the mechanism of action of
antidepressants. Leptin, an adipocyte-derived hormone, has antidepressant-like properties. However, the functional role of
leptin receptor (Lepr) signaling in glutamatergic neurons remains to be elucidated. In this study, we generated conditional
knockout mice in which the long form of Lepr was ablated selectively in glutamatergic neurons located in the forebrain
structures, including the hippocampus and prefrontal cortex (Lepr cKO). Lepr cKO mice exhibit normal growth and body weight.
Behavioral characterization of Lepr cKO mice reveals depression-like behavioral deﬁcits, including anhedonia, behavioral
despair, enhanced learned helplessness and social withdrawal, with no evident signs of anxiety. In addition, loss of Lepr in
forebrain glutamatergic neurons facilitates N-methyl-D-aspartate (NMDA)-induced hippocampal long-term synaptic depression
(LTD), whereas conventional LTD or long-term potentiation (LTP) was not affected. The facilitated LTD induction requires
activation of the NMDA receptor GluN2B (NR2B) subunit as it was completely blocked by a selective GluN2B antagonist.
Moreover,LeprcKOmicearehighlysensitivetotheantidepressant-likebehavioraleffectsoftheGluN2Bantagonistbutresistant
to leptin. These results support important roles for Lepr signaling in glutamatergic neurons in regulating depression-related
behaviors and modulating excitatory synaptic strength, suggesting a possible association between synaptic depression and
behavioral manifestation of behavioral depression.
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Introduction
Depression is a chronic and debilitating mental illness with a
17% lifetime prevalence and is a major cause of morbidity,
disability and mortality.
1–3 Research in this ﬁeld has been
dominated by the monoamine theory for over 50 years.
Currently available pharmacologic treatments for depression
primarily target monoamine systems. However, the mono-
amine-based antidepressants have signiﬁcant limitations in
efﬁcacy, safety and onset of action. Recently, there is
increasing preclinical and clinical evidence supporting a role
for the glutamatergic system in depression and antidepres-
sant activity.
4–8 Among glutamate receptor subtypes, the
N-methyl-D-aspartate(NMDA)receptorhasreceivedthemost
attention as drugs that modulate NMDA receptor functional
activity have demonstrated antidepressant-like properties in
animal models
9–16 and in patients suffering from major
depressive disorder.
17–20
Leptin, a hormone secreted from adipocytes, circulates in
the blood and enters the brain where it exerts physiological
actions beyond the control of food intake and metabolism.
Indeed, systemic or intracranial administration of leptin
produces antidepressant-like effects in both rats and
mice.
21–23 Circulating leptin levels are reduced in animals
subjected to chronic social defeat or chronic unpredictable
stress,twoanimalmodelsofdepression.
22,24Althoughresults
from clinical investigations have been inconsistent, several
studies havefoundanassociation betweenlow levelsofleptin
and major depressive disorders.
25–27 Of note, a recent study
by Lawson et al.
28 reported an inverse correlation between
leptin levels and the severity of depression symptoms. These
correlational studies suggest that leptin signaling may be
involved in the pathophysiology of major depressive dis-
orders. Leptin exerts its effects by activating the long form of
the leptin receptor (Lepr), which is widely but selectively
distributed in various brain regions such as the prefrontal
cortex and hippocampus,
29–31 two limbic brain areas impli-
cated in depression.
32–34 However, whether defects in leptin
receptor function in limbic neural circuits contributes to the
pathogenesis of depression and whether speciﬁc neuronal
populations mediate leptin’s antidepressant-like activity
are not yet known.
Inthisstudy,weproducedmiceinwhichthelongformofthe
leptin receptor was ablated speciﬁcally in glutamatergic
neurons in the dorsal forebrain, including the hippocampus
and cerebral cortex, using Cre-mediated recombination
driven bythepromoterofEmx1,ahomeoboxgene,principally
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35–37 We
characterized the behavioral, neuroendocrine and electro-
physiological phenotypes of these mice. Moreover, we
examined the responses of these mice to the antidepres-
sant-like behavioral effects of a GluN2B antagonist and leptin.
Our results suggest that Lepr signaling in forebrain glutama-
tergic neurons is critical for regulating depression-like
behaviors and induction of hippocampal long-term synaptic
depression.
Materials and methods
Animals. Emx1 is expressed principally in glutamatergic
neurons in the forebrain including cerebral cortex and
hippocampal formation.
35–37 To generate mice with ablation
of the long form of Lepr in forebrain glutamatergic neurons,
Lepr
ﬂox/ﬂox mice, in which loxP sites ﬂank exon 17 that con-
tains the Box 1 motif crucial for leptin signal transduction,
38
were mated with Emx1-Cre mice, in which Cre recombinase
was driven by the promoter of the Emx1 gene.
39 The Lepr
ﬂox/þ,
Emx1-Cre offsprings were then bred with Lepr
ﬂox/ﬂox mice for
4–5 generations. Genomic DNA was extracted and used as
the template for PCR-based genotyping. For veriﬁcation of
the Lepr
ﬂox/ﬂox alleles, the PCR products were ampliﬁed
using the primers 50-ATGCTATCGACAAGCAGCAGAATGA-
30 and 50-CAGGCTTGAGAACATGAACACAACAAC-30. The
presence of the LoxP sites was veriﬁed by digesting the PCR
product with HindIII. The Emx1-Cre allele was veriﬁed using
the primers 50-CACTCATGGAAAATAGCGATC-30 and 50-
ATCTCCGGTATTGAAACTCCAGCGC-30. All mice were
housed in groups of four or ﬁve on a 14h light/10h dark
cycle (lights on at 0700h) with ad libitum access to food and
water. All procedures were approved by the Institutional
Animal Care and Use Committee at the University of Texas
Health Science Center at San Antonio and carried out in
accordance with the National Institutes of Health Guide.
Cre expression. The Emx1-Cre knock-in construct contains
a lacZ gene coding for nuclear-localized b-galactosidase that
is linked to an internal ribosomal entry site followed by a
nuclear-localized Cre-coding region.
40 This allows for co-
expression of Cre and b-galactosidase. To conﬁrm the
expression pattern of Cre in the Lepr
ﬂox/ﬂox mouse brain,
lacZ expression was used as readout for cell-speciﬁc Cre
expression. Immunoreactivity of b-galactosidase was per-
formed as described in detail below.
Reverse transcription-PCR. Cortex, hippocampus and
hypothalamus of Lepr
ﬂox/ﬂox (fWT) and Lepr
ﬂox/ﬂox, Emx1-
Cre/þ (Lepr conditional knockout (Lepr cKO)) mice were
dissected and total RNA was extracted using Trizol reagent
(Invitrogen, Carlsbad, CA, USA). SuperScript II reverse
transcriptase (Invitrogen) was used to generate comple-
mentary DNA (cDNA) using the oligo(dT)25. The reaction
mixture consisted of 4mg of total RNA, 500ng oligo(dT)25,
4mlo f5  First-Strand buffer, 10mM dithiothreitol, 40 units of
RNaseOUT (Invitrogen) and 200 units of SuperScript II
reverse transcriptase (Invitrogen). The resulting cDNA was
used for PCR ampliﬁcation of Lepr exon 17 or b-actin with
Accuprime pfx Supermix (Invitrogen). The PCR mix
consisted of 22ml of the Accuprime pfx Supermix with 1ml
of each primer (10mM stock) and 1ml cDNA. The conditions
for PCR were 941C for 5min, followed by 35 cycles of 941C
for 1min, 601C for 1min and 721C for 1min, followed by a
ﬁnal incubation at 721C for 10min. The primer sequences
used to amplify each product are as follows: Lepr exon 17,
forward: 50-GGGACGATGTTCCAAACCCCA-30 and reverse:
50-AGGCTCCAGAAGAAGAGGACC-30; b-actin, forward: 50-
AGCCATGTACGTAGCCATCC-30 and reverse: 50-TGTGGT
GGTGAAGCTGTAGC-30. The PCR products were analyzed
on a 1% agarose gel with ethidium bromide.
Real-time reverse transcription-PCR. Primers speciﬁc for
exon 17 of Lepr or b-actin were used to amplify a single
PCR product from each cDNA sample. Real-time PCR was
performed on a Realplex2 Mastercycler (Eppendorf, Westburg,
NY, USA) and analyzed using Mastercycler EP Realplex,
version 1.5. The ampliﬁcation mixture contained 25ml of the
Power SYBRGreen PCR Master Mix (Applied Biosystems,
Carlsbad, CA, USA), 1ml of each primer (10mM stock), 1mlo f
cDNA template and 22ml of PCR-grade water. The cycling
conditions began with a hot start at 951C for 5min followed
by 40 cycles of 95, 60 and 721C for 1min each. The
reactions were performed in duplicate. Control reactions
consisting of master mix and primers but excluding cDNA
template were run in parallel. The Ct values for each
duplicate were averaged and used for quantiﬁcation. The
relative amount of mRNA for Lepr exon 17 for each sample
was normalized to b-actin mRNA using the following formula:
2
(CTexon 17 – CTb-actin).
Measurement of body weight and body composition. For
Lepr cKO mice and fWT littermate controls, body weight was
recorded once per week from 4 to 12 weeks of age. Body
composition in 14-week-old mice was measured by dual-
energy X-ray absorptiometry (GE Medical Systems, Madison,
WI, USA). The instrument was calibrated using the phantom
mouse model accompanied with the machine, and quality
control was performed before the detection of animals.
Behavioral procedures. All behavioral tests used adult
mice (9–12 weeks old) and were performed during the late
light phase except sucrose preference that was measured
every 24h. On the test day, animals were singly housed in a
new cage with some home cage bedding to avoid the
stressful effect of removal from their home cage. Animals
were transferred to the testing room and habituated to the
room conditions for 3 to 4h before the beginning of the
experiments. After each individual test session, the apparatus
was thoroughly cleaned with 20% alcohol to eliminate the odor
and trace of the previously tested animals. All behaviors were
scored by experimenters who were blind to the treatments and
genotypes.
Locomotor activity. On the testing day, the home cage lid
was replaced by clear Plexiglas to enable recording of
animal’s activity using a CCD (charge-coupled device) camera
mounted above the cage. Locomotor activity was monitored
and recorded for 30min. The total distance traveled in 30min
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system (Noldus Information Technology, Leesburg, VA, USA).
Rotarod test. Mice were trained for 2 days on the rotarod at
ﬁxed speeds of 5, 15 and 30r.p.m. for 5min each. On the
third day, mice were tested on the rotarod at accelerating
speeds from 4 to 40r.p.m. over 5min. The latency for each
mouse to fall from the rod was recorded.
Behavioral despair tests. Mice were assessed in the tail
suspension test and the forced swim test. The tail sus-
pension apparatus was a wooden box (30 30 30cm). The
front of the box was open, and a horizontal bar was placed
1cm from the top with an attached vertical bar hanging down
in the center. Mice were individually suspended by the tail to
the vertical bar with adhesive tape afﬁxed 2cm from the tip of
the tail. A CCD camera was positioned in front of the tail
suspension test box and the animal’s behavior was recorded
for 6min. Immobility is deﬁned as the absence of any limb or
body movements, except those caused by respiration. For
the forced swim test, mice were placed in a clear Plexiglas
cylinder (25cm high; 10cm in diameter) ﬁlled with 241C
water to a depth of 15cm. Fresh water was used for each
animal. A CCD camera positioned directly above the cylinder
recorded the swim session. In a 6-min test session, the
ﬁrst 2min were designated as a habituation period and
the duration of immobility during last 4min was measured
using Noldus EthoVision 3.0 system (Noldus Information
Technology).
21
For evaluating the antidepressant-like behavioral effects of
leptin (R&D Systems, Minneapolis, MN, USA) or Ro25-6981
(Sigma, St Louis, MO, USA), the drugs were dissolved in
saline immediately before use and administered intraperito-
neally to mice 30min before the tail suspension test or the
forced swim test. The testing procedures and scoring
methods were the same as described above.
Sweet solution preference. Mice were habituated to drinking
from two bottles of water for 1 week before testing. To
measure the preference for sweet solutions, the animals
were singly housed and tested with one bottle of water and
one bottle of either 1% sucrose or 0.01% saccharin for 4 con-
secutive days. Water and sucrose or saccharin intake were
measured daily and the position of two bottles was switched
every day to avoid side preference. Sucrose or saccharin
preference was calculated as the mass of sucrose or sac-
charin solution consumed over the total mass of ﬂuid intake.
Learned helplessness test. This test was performed in a
shuttle cage that was divided equally into two chambers
with an auto-controlled guillotine door. Learned helplessness
was induced in mice by administering 200 scrambled,
inescapable foot shock (0.3mA shock amplitude, 2-s
duration, 16-s average interval) over a 1-h session. Control
animals were exposed to the apparatus for the same period
of time without receiving foot shocks. Escape performance
was tested 24h later in the same shuttle chamber. Each
mouse was given 30 shuttle escape trials with 25s maximum
duration and 30-s intervals. On the ﬁrst ﬁve trials, a sound
cue and the shock took place at the same time as the door to
the safe compartment opened. For the remaining trials, the
door opened 2s after the shock was delivered. Each trial was
terminated when the mouse crossed into the non-shock
compartment. Latency to escape and the number of escape
failure were recorded automatically by the Graphic State
software (Coulbourn Instruments, Allentown, PA, USA).
Hot-plate test. Pain sensitivity was assessed by detecting
the reﬂexes in the hot-plate test. The surface of the hot plate
was heated to a constant temperature of 551C. Mice were
placed on the hot plate with surrounded wall. The duration of
the test session was a maximum of 30s. The latency to
respond with hindpaw lick, hindpaw ﬂick or jump was
recorded. The mouse was immediately removed from the
hot plate and returned to its home cage. If the mouse did not
respond, the test was terminated after 30s.
Chronic social defeat. This was conducted using a resident–
intruder paradigm as previously reported.
41–44 Brieﬂy, each
male fWT and Lepr cKO mouse was individually introduced
to the home cage of an unfamiliar aggressive CD1 resident
mouse for 10min and physically defeated. After the defeat,
the resident CD1 mouse and the intruder mouse were
housed together but separated by a perforated plastic divider
to allow visual, olfactory and auditory contact for the remainder
of the 24-h period. Mice were exposed to a new resident CD1
mouse and subjected to social defeat each day for 10
consecutive days. Non-defeated control mice were housed
two per cage in cages identical to those used for the socially
defeated mice. At 24h after the last social defeat session,
mice were subjected to the social interaction/avoidance test,
w h i c hw a sp e r f o r m e di na4 0 40cm arena with infrared light
illumination. The approach–avoidance behavior of mice was
recorded with a video tracking system. Each test consisted of
two 2.5-min sessions. In the ﬁrst 2.5-min ‘no target’ session,
the mouse was introduced to the open arena with an empty
wire mesh cage (10 6.5 5cm) as indicated in Figure 2g. For
the second 2.5-min session with target, an unfamiliar CD1 male
mouse was placed into the wire mesh cage. The wire mesh
cage allowed visual and olfactory interactions between the test
mouse and the target CD1 mouse and prevented direct
physical contact. The time spent in the ‘interaction zone’
(25 14cm) located around where the wire mesh cage was
located and in the ‘avoidance zone’ (on the side opposite to the
interaction zone, 40 10cm) were measured using EthoVision
3.0 software. Social preference ratio was calculated as time in
the interaction zone/(time in the interaction zoneþtime in the
avoidance zone).
Elevated plus maze (EPM). The EPM was made of black
acrylic, with four arms (30cm long and 5cm wide) arranged
in the shape of a ‘plus’ sign and elevated to a height of 70cm
from the ﬂoor.
45 Two arms have no side or end walls (open
arms). The other two arms have side walls and end walls
(12cm high) but are open on top (closed arms). The open
and closed arms intersect, at a central 5 5cm square
platform giving access to all arms. The mice were placed in
the central square facing the corner between a closed arm
and an open arm, and their exploration was videotaped. The
numbers of entries and the time spent on each arm were
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tioned within one arm. The degree of anxiety was assessed
by calculating the percentage of open arm entries (entries
into the open arms/total entries into all arms) and percentage
of open arm time (time spent in the open arms/total time
spent in all arms).
Open-ﬁeld test. The apparatus was made of plastic coated
wood and consisted of a 60 60cm open arena with 40cm
high walls. The open ﬁeld arena was divided into nine equal
squares. The center square was deﬁned as the central zone,
in which the animal’s activity is usually regarded as a
measure of anxiety. The entire test arena was adjusted to
even illumination. Mice were placed in the center of the
arena, and their activity in the arena was recorded for 5min
using a CCD camera. The percent time mice spent in the
central zone and the total distance traveled in the open arena
were quantiﬁed using the Noldus EthoVision 3.0 system. The
overall motor activity during the open ﬁeld test was assessed
as the total distance traveled.
Light/dark choice. This test is based on a natural conﬂict of a
mouse between the innate aversion to brightly illuminated
areas and the exploration of a novel environment. The
apparatus consisted of two equally sized compartments
(17.8 17.8 30.5cm) divided by a wall with an opening at
the ﬂoor level. The light compartment was brightly illuminated
with light intensity of 700lux; and the dark compartment was
black walled. Mice were placed individually in the center of
the light compartment facing away from the opening. The
number of transitions between two compartments and time
spent in the light compartment were recorded over 5min.
Visual cliff test. This test measures the ability to avoid a
visual cliff.
45 The apparatus is used to evaluate the ability of
the animal to see the drop-off at the edge of a horizontal
surface. A box with the inner surface covered with chec-
kerboard paper was connected to a vertical drop of 0.7m. A
sheet of clear Plexiglas provided a solid horizontal surface in
spite of the visual appearance of a cliff. Each mouse was
subjected to 10 consecutive trials. Normal mice stop at the
‘edge’. The visually impaired animals cannot detect the ‘cliff’
and will move forward across the ‘cliff’ without pause.
Mice that were naı ¨ve to behavioral testing were used for
assessing locomotor activity, tail suspension, forced swim,
sweet solution preference, learned helplessness, chronic
social defeat and EPM. The rotarod and visual cliff tests were
performed on the mice used for the locomotion test; the hot-
plate test was performed on the mice following the learned
helplessness test; the open-ﬁeld test and light/dark choice
were performed using the same cohort of mice.
Plasma corticosterone, insulin and leptin level
analysis. Plasma corticosterone was assayed using the
radioimmunoassay method. Brieﬂy, 10-ml duplicate samples
of plasma were heated at 701C for 30min to denature
corticosterone-binding protein, and incubated overnight with
corticosterone antibody (Chemicon International, Temecula,
CA, USA) and [
3H]corticosterone (PerkinElmer, Boston, MA,
USA). Free and bound corticosterone were separated by
incubation with charcoal for 15min. The levels of plasma
insulin and leptin were measured using mouse insulin and
leptin ELISA kits, respectively (Alpco Diagnostics, Salem,
NH, USA). Plasma was diluted 1:5 in a dilution buffer and
immobilized in 96-well plates coated with speciﬁc antibodies
conjugated to horseradish peroxidase and quantiﬁed by a
chromogenic substrate.
Immunohistochemistry. Immunohistochemistry was per-
formed as described previously.
46 Mouse brains were ﬁxed
in 4% paraformaldehyde and cut into 40-mm coronal
sections. For the detection of b-galactosidase in Lepr
ﬂox/ﬂox,
Emx1-Cre/þ mice, the brain sections were ﬁrst incubated
with rabbit anti-b-galactosidase (1:100, Abcam, Cambridge,
MA, USA), followed by goat anti-rabbit conjugated to Alexa-
Fluor 488 (1:400, Molecular Probes, Eugene, OR, USA).
In situ hybridization. Antisense cRNA probes directed
against the sequence of the mouse leptin receptor C-
terminus glucocorticoid receptor and corticotropin-releasing
hormone mRNA were labeled with S
35-UTP (uridine tripho-
sphate) and S
35-CTP (cytidine triphosphate) (PerkinElmer,
Waltham, MA, USA) using the standard transcription system
as described in our previous studies.
47,48 Brieﬂy, coronal brain
sections were cut and mounted onto polylysine-coated slides.
The brain sections were ﬁxed in 4% paraformaldehyde for 1h,
rinsed in 2  SSC (300mM NaCl, 30mM Na citrate, pH 7.2)
three times (5min each). The slides were then acetylated in
0.1 M triethanolamine (pH 8.0) with 0.25% acetic anhydride for
10min and dehydrated through a graded series of alcohol
(50–100%). Hybridization was conducted by the addition of
70ml of the diluted radiolabeled probe to the slide and
incubation at 551C overnight. The slides were rinsed in 2 
SSC and incubated in RNase A buffer (200mgml
–1)f o r1ha t
371C, followed by a series of washes of increasing stringency
(2 ,1 ,0 . 5  SSC). Finally, the slides were placed in 0.1 
SSC at 701C for 1h, rinsed in distilled water, dehydrated in a
graded series of alcohol and were exposed to X-ray ﬁlm.
Electrophysiology. Coronal hippocampal slices (400mm)
were prepared from 8- to 12-week-old male mice. Brieﬂy,
hippocampal slices were cut using a vibrating microtome
(NVSLM1, WPI, Sarasota, FL, USA) in ice-cold slicing buffer
(in mM: 127 NaCl, 26 NaHCO3, 1.2 KH2PO4, 1.9 KCl, 1.1
CaCl2, 2 MgSO4 and 10 D-Glucose) bubbled with 95% O2
and 5% CO2. Slices were then transferred to a holding
chamber containing oxygenated artiﬁcial cerebrospinal ﬂuid
(ACSF; in mM: 127 NaCl, 26 NaHCO3, 1.2 KH2PO4, 1.9 KCl,
2.2 CaCl2, 1 MgSO4 and 10 D-Glucose) for 30min at 341C
and for another 30min at 221C for recovery, and then tran-
sferred to a submersion recording chamber while continually
perfused with 321C oxygenated ACSF (rate: 2mlmin
–1).
Slices were equilibrated for at least 15min before each
recording.
ACSF-ﬁlled glass electrodes (resistance o1MO) were
positioned in the stratum radiatum of area CA1 for extra-
cellular recording. Synaptic responses were evoked by sti-
mulating Schaffer collaterals with 0.2ms pulses with a bipolar
tungsten electrode (WPI) once every 15s. The stimulation
intensity was systematically increased to determine the
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and then adjusted to yield 40–60% of the maximal (fEPSP)
slope. Experiments with maximal fEPSPs of o0.5mV or with
substantial changes in the ﬁber volley were rejected. After
recording of a stable baseline for 15min, long-term potentia-
tion (LTP) was induced by one 1s per 100Hz stimulus train,
and long-term depression (LTD) was induced by 900 pulses
delivered with a frequency of 1Hz in the absence or presence
of L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC; Sigma), a
glutamate transporter inhibitor, and ifenprodil (Sigma), a
GluN2B selective antagonist.
Field EPSPs were recorded (AxoClamp 2B ampliﬁer, Axon
Instruments, Foster City, CA, USA), ﬁltered at 1kHz, digitized
at 10kHz (Axon Digidata 1322A) and stored for off-line
analysis (Clampﬁt 9). Whole-cell recordings from CA1
pyramidal neurons were made using an Axopatch 200B
ampliﬁer (Axon Instruments), sampled at 10kHz, digitized by
a DigiData 1322A and later analyzed off-line by ClampFit
(Axon software). Whole-cell patch pipettes with resistances
ranging between 3 and 7MO were pulled using standard
borosilicate capillaries by an upright PB-7 electrode puller
(Narishige, East Meadow, NY, USA) and were ﬁlled with a Cs-
gluconate-based patch solution (in mM: 125 Cs-gluconate, 20
CsCl, 10 NaCl, 2 Mg-ATP, 0.3 Na-GTP, 2.5 QX314, 10
PIPES, 0.2 EGTA, pH 7.3 adjusted with CsOH). Synaptic
currents were evoked by monopolar stimulation at a rate of
0.05Hz via a silver wire housed in an ACSF-ﬁlled glass
electrode (1–2MO) placed in the Schaeffer collaterals.
Magnitude and rate of extracellular stimulation were con-
trolled with a Master-8 stimulator (AMPI, Jerusalem, Israel).
To determine the a-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionicacidreceptor(AMPAR)/NMDA receptor(NMDAR)
current ratio, whole-cell recordings were performed at
a holding potential of þ40mV in the presence of a
g-Aminobutyric acid A receptor antagonist, picrotoxin (50mM,
Sigma). Baseline responses were recorded in the absence of
APV (2-amino-5-phosphonovaleric acid) to determine the
combined AMPAR- and NMDAR-evoked excitatory post-
synapticcurrents(eEPSCs,atleast10traces).Subsequently,
evoked responses were recorded in the presence of 100mM
APV to determine AMPAR eEPSCs (at least 10 traces). The
average NMDAR eEPSC amplitude was calculated by
subtractingthe averaged AMPAR eEPSCs from the averaged
combined AMPAR/NMDAR eEPSCs.
Statistical analysis. Results are expressed as mean±
s.e.m. Statistical analyses were performed using one-way
analysis of variance (ANOVA) with repeated measures on
the effect of genotype on body weight gain and locomotor
activity; two-way ANOVA with repeated measures on escape
latencies with genotype and foot shock as main factors and
two-way ANOVA without repeated measures on number of
failures to escape in the learned helplessness test; two-way
ANOVA on corticosterone levels with genotype and restraint
stress as main factors and immobility time in the tail
suspension and forced swim tests with genotype and drug
treatment as main factors; three-way ANOVA on time spent
in the social interaction and avoidance zones and social
preference ratio in the chronic social defeat paradigm with
genotype, defeat and target as main factors. Bonferroni/
Dunn post hoc comparisons followed ANOVAs. Two-tailed
Student’s t-test was used for statistical analysis of the rest of
experimental results. Po0.05 was considered statistically
signiﬁcant.
Results
Generation of mice with ablation of the long form of Lepr
in forebrain glutamatergic neurons. The ablation of the
long form of Lepr was induced by crossing Lepr
ﬂox/ﬂox with
mice bearing the Emx1-Cre transgene,
39 which is expressed
principally in glutamatergic neurons of the hippocampal
formation and dorsal cerebral cortex.
35–37 Immunohistoche-
mical detection of b-galactosidase, a readout of cell-speciﬁc
Emx1-Cre expression,
39,40 conﬁrmed that Cre expression
was restricted to neurons located in the hippocampus and
cerebral cortex in Lepr
ﬂox/ﬂox, Emx1-Cre/þ (Lepr cKO)
(Figure 1a). Reverse transcription-PCR analysis showed
that exon 17 of Lepr mRNA was almost abolished in the
hippocampus and cortex, but unaltered in the hypothalamus,
indicating that Cre-mediated deletion of Lepr in Lepr cKO
mice was speciﬁc to the hippocampus and cerebral cortex
(Figure 1b). Real-time PCR results conﬁrmed the deletion of
490% of Lepr in the hippocampus and cortex in Lepr cKO
mice (Figure 1c).
General physical and hormonal assessments of Lepr
cKO mice. Body weight of Lepr cKO mice and fWT
littermate controls were monitored from 4 to 12 weeks of
age. Mice exhibited similar body weight gain and showed no
genotype difference (F(1,288)¼0.063, P40.5 for males;
F(1,280)¼1.100, P40.1 for females; Figure 1d). Body com-
position was analyzed using dual-energy X-ray absorp-
tiometry at 14 weeks of age. Fat mass and lean mass were
similar between the two genotypes (males: fat mass t(14)¼
0.056, P40.5; lean mass t(14)¼0.361, P40.5. females: fat
mass t(14)¼0.413, P40.5; lean mass t(14)¼0.427, P40.5;
Figure 1e). These results indicate that growth rate and fat
deposition are not altered by deletion of Lepr in forebrain
glutamatergic neurons. In consistence with normal body
weight and adiposity, plasma levels of leptin and insulin were
indistinguishable between the two genotypes (t(8)¼1.068,
P40.1 for leptin; t(8)¼0.933, P40.1 for insulin; Figures 1f
and g).
Many tests for depression- and anxiety-related behaviors
dependuponpropermotorandvisualfunctions.Weexamined
locomotor activity in Lepr cKO mice. No differences in the
distance traveled within 30min were observed between Lepr
cKO mice and fWT littermate controls (males: F(1,266)¼
0.587, P40.1 for the time course of the distance traveled
every 2min; t(19)¼0.766, P40.1 for the total distance
traveled within 30min; Figure 2a, females: F(1,224)¼0.034,
P40.5 for the time course of distance traveled every 2min;
t(16)¼0.185, P40.5 for the total distance traveled within
30min; Figure 2b). To examine motor coordination, we per-
formed therotarodtest.Lepr cKO and fWT control mice showed
similar latencies to fall (males: fWT 164±23s, Lepr cKO
172±27s; t(18)¼0.224, P40.5; females: fWT 152±18s,
Lepr cKO 130±16s; t(36)¼0.883, P40.1). These results
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and motor coordination. To evaluate visual acuity, we
performedthevisualclifftestinmiceattheageof13weeks.
The fW Tc o n t r o lm i c es h o w e d7 3 ±6.2% safe responses
and Lepr cKO mice exhibited 73±4.1% safe responses,
suggesting that both genotypes are capable of pattern
discrimination and have no gross vision impairments at the
age tested.
Behavioral phenotypes of Lepr cKO mice
Depression-like behaviors. To determine whether inactiva-
tion of Lepr in forebrain glutamatergic neurons affects mood-
related behaviors, we performed a series of behavioral tests.
The tail suspension test and forced swim test have been
widely used to assess ‘despair behavior’,
49,50 in which
animals are subjected to an inescapable stressful situation
and subsequently adopt an immobile posture. The duration
of immobility, referred to as ‘despair’, is attenuated by a
variety of antidepressants.
51,52 Both male and female Lepr
cKO mice showed a signiﬁcantly longer immobility time than
fWT littermate controls in the tail suspension test (males:
t(17)¼3.282, Po0.01; females: t(15)¼3.129, Po0.01; Figure 2c)
and forced swim test (males: t(19)¼2.18, Po0.05; females:
t(15)¼6.836, Po0.001; Figure 2d). The increased immobility
in Lepr cKO mice is unlikely due to hypolocomotion because
the locomotor activity and motor coordination were normal in
Lepr cKO mice.
A core symptom of human depression is anhedonia, or the
inability to experience pleasure. The preference for sweet
solutions over plain water has been used as a paradigm to
measure hedonic response to natural reward in rodents.
53
Mice were habituated to two drinking bottles in their home
cage and then allowed free access to a choice of water and a
sweet solution for 4 days. Lepr cKO mice showed signiﬁcantly
Figure1 GenerationofmicelackingLeprinforebrainneurons.(a,leftpanel)InsituhybridizationshowingthelongformofLepr(Lepr-b)mRNAexpression.(a,rightpanel)
Fluorescenceimmunohistochemistryofb-galactosidaseindicatingthatCreactivityunderthecontrolofEmx1promoterwasrestrictedtothehippocampalandcorticalneurons.
(b) Reverse transcription-PCR analysis of gene expression of Exon 17 of the leptin receptor in the hippocampus, cortex and hypothalamus. (c) Real-time quantitative PCR
analysis of gene expressionof Exon 17 of Lepr in the hippocampus, cortex and hypothalamus. *Po0.05 compared with fWT controls. (d) Body weight gain of Lepr cKO mice
and fWT littermate controls in males and females from 4 to 12 weeks of age. Male fWT, n¼19; male Lepr cKO, n¼19; female fWT, n¼17; female Lepr cKO, n¼20. (e)
Body composition in both male and female mice; n¼8 per group. (f) Plasma concentrations of leptin; n¼5 per group. (g) Plasma concentrations of insulin; n¼5 per group.
All data are presented as mean±s.e.m.
Leptin receptor signaling in forebrain glutamatergic neurons
M Guo et al
6
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controls (t(34)¼2.198, Po0.05; Figure 2e). To rule out the
potential confounding effect of caloric intake in the sucrose
preference test, we subsequently tested the mice with 0.01%
saccharin, a noncaloric sweetener. A signiﬁcant reduction
in saccharin preference was observed in Lepr cKO mice
Figure 2 Lepr cKO mice exhibit depression-like behaviors. (a, b) Locomotor activity. Locomotor activity was monitored for 30min and analyzed in 2-min bins. The inserts
indicating the total distance traveled during the 30-min test. Male fWT, n¼10; male Lepr cKO, n¼11; female fWT, n¼8; female Lepr cKO, n¼10. (c) Tail suspension test.
Immobility timewasmeasuredduringthe6-mintest period.MalefWT, n¼8; maleLeprcKO,n¼11;femalefWT, n¼7; femaleLeprcKO,n¼10.**Po0.01 comparedwith
the littermate fWT control group. (d) Forced swim test in both males and females. Immobility time was measured during the last 4min of the 6-min test period. Male fWT,
n¼10; male Lepr cKO, n¼11; female fWT, n¼8; female Lepr cKO, n¼9. *Po0.05, ***Po0.001 compared with the littermate fWT control group. (e) Sweet solution
preferencetestsinmalesexpressedaspercentsucrosesolution(1%)orsaccharin(0.01%)intakewithina4-daytest(sucroseorsaccharinsolutionintake/totalintake  100).
Leftyaxis,sucrosepreference;n¼18per group.Rightyaxis,saccharine preference;n¼9forfWT,n¼10forLeprcKO.*Po0.05comparedwith thelittermatefWTcontrol
group. (f) Learned helplessness test in male mice. (Left panel) Escape latency. (Right panel) Number of failures to escape; n¼10–13 per group. *Po0.05, ***Po0.001
compared with the fWT, Shock group. (g) Social interaction and avoidance in male mice. (Top) Representative tracks of control (left) or socially defeated (right) fWT or Lepr
cKOmiceinanarenainthepresenceofanaggressiveCD1mouseinthetargetarea.(Bottom-leftpanel)Timespentintheinteractionzone.(Bottom-middlepanel)Timespent
in the avoidance zone. (Bottom-right panel) Social preference ratio deﬁned as time in the interaction zone/(time in the interaction zone þ time in the avoidance zone) 100.
n¼8–11pergroup.**Po0.01,***Po0.001comparedwithrespectivecontrolconditioninfWTandLeprcKOmice;
#Po0.05,
##Po0.01comparedwithdefeatedfWTmice.
All data are expressed as mean±s.e.m.
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Figure 2e). These results indicate a hedonic-like phenotype in
Lepr cKO mice.
To determine if loss of Lepr in glutamatergic neurons
increases the vulnerability to stress-induced depression-like
behaviors, Lepr cKO mice were tested using the learned
helplessness paradigm. Animals were exposed to inescap-
able foot shock stress and subsequently tested for a coping
deﬁcit in avoidance-escape performance. Escape deﬁcits in
this test are sensitive to reversal by antidepressant treat-
ments.
54 Lepr cKO mice exhibited signiﬁcant increase in
escape latency (F(1,215)¼5.020, Po0.05) and number of
escape failure (F(1,43)¼9.031, Po0.01; Figure 2f). To ensure
that the escape deﬁcit of Lepr cKO was not due to alteration in
pain sensitivity, we performed the hot-plate test to measure
the pain reﬂex threshold of the footpad contacting a heated
surface. No difference in hot-plate response latencies was
observed between Lepr cKO mice and fWT littermate controls
(fWT 24.4±3.5s, Lepr cKO 24.3±5.4s; t(16)¼0.052,
P40.5), suggesting that the behavioral changes in the
learned helplessness test represent true coping deﬁcits.
Chronic social defeat stress using the resident–intruder
paradigm has been validated as an animal model of depres-
sion.
41,44TodeterminewhetherLeprdeletioninglutamatergic
neurons confers a vulnerability to stress-induced social
avoidance, male Lepr cKO mice and fWT littermate control
mice were subjected to social defeat in the home cage of an
unfamiliar aggressive CD1 mouse each day for 10 days.
Social interaction was examined for two 2.5-min sessions in
the absence or presence of a ‘target’ CD1 mouse, respec-
tively,at24hafterthelastsessionofsocialdefeat(Figure2g).
ANOVA analyses showed signiﬁcant effects of social defeat
on the time spent in the interaction zone (F(1,64)¼43.301,
Po0.001) and the avoidance zone (F(1,64)¼25.738,
Po0.001) and on social preference ratio (F(1,64)¼30.388,
Po0.001) and signiﬁcant effects of genotype on the time
spent in the avoidance zone (F(1,64)¼5.772, Po0.05) and
social preference ratio (F(1,64)¼4.605, Po0.05). There were
signiﬁcant defeat genotype interactions observed on time
spent in the avoidance zone (F(1,64)¼5.228, Po0.05) and
social preference ratio (F(1,64)¼4.172, Po0.05). Post hoc
comparisons indicated that time spent in the avoidance zone
was increased and social preference ratio was decreased in
Lepr cKO mice compared with fWT littermate controls during
the presence of a ‘target’ CD1 mouse (Figure 2g). This
suggests that loss of Lepr in forebrain glutamatergic neurons
enhances stress-induced social aversion.
Anxiety-like behaviors. To assess whether depression-like
behaviors in Lepr cKO mice are accompanied by anxiety-like
behaviors, we performed three behavioral tests to evaluate
anxiety levels: the EPM, the open-ﬁeld test and the light/dark
choice. In the EPM, reduced time spent in the open arms and
numbers of entries made into the open arms within the 5min
test are taken as indices of anxiety. There were no differ-
ences in time spent in the open arms (males: t(16)¼0.270,
P40.5; females: t(14)¼0.260, P40.5) or entries into
the open arms (males: t(16)¼0.371, P40.5; females: t(14)¼
0.182, P40.5) between Lepr cKO and fWT mice
(Supplementary Figure S1A). When placed in an open ﬁeld
arena, anxious mice tend to spend less time in the center and
more time in the corners. Lepr cKO and fWT mice spent
similar amounts of time in the central zone (males: t(18)¼
0.182, P40.5; females: t(15)¼0.870, P40.1) and traveled
similar total distances within the arena (males: t(18)¼0.003,
P40.5; females: t(15)¼1.936; P40.05; Supplementary
Figure S1B). In the light/dark choice test, there were no
differences in the amount of time spent in the light box
(males: t(15)¼0.338, P40.5; females: t(23)¼1.007, P40.1)
or the total number of transitions between light and dark
boxes (males: t(15)¼0.682, P40.5; females: t(23)¼0.796,
P40.1; Supplementary Figure S1C). Collectively, these tests
demonstrate that anxiety-like behaviors are not affected by
loss of Lepr in forebrain glutamatergic neurons.
Hypothalamic–pituitary–adrenal (HPA) axis activity in
Lepr cKO mice. The HPA axis hyperactivity is an important
mechanism in the pathogenesis of depression.
55,56 The HPA
axis activity is under the negative control of hippocampus.
57,58
Therefore, we determined whether deletion of Lepr in fore-
brain glutamatergic neurons would affect HPA axis activity.
First, we measured glucocorticoid receptor mRNA in the
hippocampus using semiquantitative in situ hybridization.
The levels of glucocorticoid receptor mRNA in CA1, CA3 and
dentate gyrus of the hippocampus were indistinguishable
between Lepr cKO mice and fWT littermate controls (CA1
t(6)¼0.007, P40.5; CA3 t(6)¼0.881, P40.1; dentate gyrus
t(6)¼1.151, P40.1; Figure 3a). Second, corticotropin-
releasing hormone mRNA expression in the paraventricular
nucleus of the hypothalamus was examined and showed no
difference between the two genotypes (t(6)¼1.723, P40.1;
Figure 3b). Moreover, plasma levels of corticosterone were
determined under basal and stressed conditions. Lepr cKO
mice displayed a normal diurnal rhythm in plasma corti-
costerone concentrations as compared with fWT mice
(t(8)¼0.357; P40.5 for the morning and t(10)¼0.267;
P40.5 for the afternoon; Figure 3c). The responsiveness
of corticosterone to stress was determined by subject-
ing animals to 30min restraint stress. ANOVA showed
signiﬁcant effect of stress (F(2,26)¼275.728; Po0.001) but
not genotype (F(1,26)¼2.785; P40.1) or stress genotype
interaction (F(2,26)¼1.472; P40.1) on corticosterone levels.
Restraint stress-induced elevation of corticosterone levels
were similar between the two genotypes (Figure 3d). These
results indicate that Lepr cKO mice have normal HPA axis
function.
Hippocampal synaptic plasticity in Lepr cKO
mice. Neuroplasticity has been proposed as a mechanism
underlying the development of major depressive disorder.
59,60
Abnormal hippocampal synaptic plasticity has been observed
in chronic mild stress, an animal model of depression, and
antidepressants can reverse this effect.
61–63 To determine
whether hippocampal synaptic plasticity is affected in Lepr
cKO mice, we performed systematic analysis of synaptic
functions in the hippocampus. The fEPSPs were recorded at
CA3–CA1 Schaeffer collateral synapses in hippocampal
slices derived from adult Lepr cKO and fWT mice (8–12
weeks). Initial characterization of Lepr cKO slices revealed
no obvious deﬁcits in the basic properties of CA1 synapses.
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used to induce LTP. The high-frequency stimulation
produced almost identical LTP in Lepr cKO and fWT mice
(fWT: 152±8%; Lepr cKO: 152±9%, measured 55–60min
after tetanus; Figure 4a). Induction of LTD by low-frequency
stimulation (LFS; 15min, 1Hz) was examined in adult
hippocampal slices. LFS failed to induce LTD in fWT
control mice (95±2% at 70–75min, Figure 4b). This is not
surprising because LFS-induced LTD is age dependent and
is observed in juvenile but not adult wild-type mice.
64–66 LFS
also did not induce LTD in Lepr cKO mice (Figure 4b). The
fEPSP slope recorded at 70–75min after the onset of LFS
was 99±5% of the baseline recorded before the application
of LFS. The input–output curves in Lepr cKO and fWT were
virtually indistinguishable (Figure 4c), suggesting that
deletion of Lepr in glutamatergic neurons does not affect
basal synaptic transmission. Similarly, there was no differ-
ence in paired-pulse facilitation, a measure of presynaptic
release probability, over the whole range of interstimulus
intervals between the two groups (Figure 4d).
The standard LFS-induced plasticity only accesses a
fraction of available synapses. LTD can also be induced
chemically by a brief application of NMDA to the hippocampal
slices,
67,68 which activates synaptic as well as extrasynaptic
NMDA receptors.
69 Application of NMDA for 7min resulted in
a transient depression of synaptic efﬁcacy that almost
returned to baseline within o30min in fWT control slices
(Figure 5a). Surprisingly, the same NMDA perfusion induced
a robust LTD in Lepr cKO slices (Figure 5a). At least two
possible mechanisms may underlie the enhancement of
NMDA-induced LTD. First, a deﬁcit in the developmental
switch from GluN2B to GluN2A (NR2A) may result in CA1
synapses containing more GluN2B, which has much slower
decay time and is implicated in LTD. However, whole-cell
recording of evoked synaptic currents indicated that the ratio
of NMDAR/AMPAR currents was unaltered in Lepr cKO
synapses (Supplementary Figure S2A). This, together with
the ﬁnding that basal synaptic transmission is normal in Lepr
cKOslices(Figure4c),indicatesthatsynapticNMDARactivity
is not grossly elevated in the synapses of Lepr cKO to cause
Figure 3 The hypothalamic–pituitary–adrenal (HPA) axis activity in Lepr cKO mice. (a) Glucocorticoid receptor (GR) mRNA expression in the hippocampus. (Left panel)
RepresentativeautoradiogramsshowingGRmRNAexpressionincoronalbrainsectionsfromfWTandLeprcKOmice.(Rightpanel)Quantitativedataindicatingrelativelevels
of GR mRNA in the hippocampus; n¼4 per group. DG, dentate gyrus. (b) Corticotropin-releasing hormone (CRH) mRNA expression in the paraventricular nucleus of
hypothalamus (PVN). (Left panel) Representative autoradiograms showing CRH mRNA expression in coronal brain sections from fWT and Lepr cKO mice. (Right panel)
QuantitativedataindicatingrelativelevelsofCRHmRNAinthePVN;n¼4pergroup.(c)Baselinecorticosteronelevelsinplasma,measuredintheearlymorning(0900h,2h
after light on) and in the late afternoon (1900h, 2h before light off). (d) Stress-induced corticosterone secretion. Trunk blood samples were collected after rapid decapitation.
Plasmacorticosterone levels were measured before exposure to restraint stress (RS), at the end of 30min restraint and 30min after the cessation of restraint stress; n¼5–6
per group. All data are presented as mean±s.e.m.
Leptin receptor signaling in forebrain glutamatergic neurons
M Guo et al
9
Translational Psychiatryenhanced LTD. Furthermore, the decay time of NMDA
currents at fWT and Lepr cKO synapses was quite similar,
suggesting that GluN2B/GluN2A ratio is not dramatically
increased at the synapses of Lepr cKO mice (Supplementary
Figure S2B). Thus, a deﬁcit in the developmental switch from
GluN2A to GluN2B is less likely. The second possibility is that
Lepr deletion results in an increase in extrasynaptic NMDAR
activity. To test this, LTD-inducing protocol was applied in the
presence of PDC (a glutamate transporter inhibitor), which
reduces glutamate uptake at the synaptic cleft and therefore
increasesglutamatespillovertoextrasynapticsitestoactivate
extrasynapticNMDAR.IfNMDA-inducedLTDistrulybecause
of extrasynaptic NMDAR, LFS should now be able to induce
LTDin adultCA1 synapses.Indeed,amild LTD wasobserved
75min after 1Hz stimulation in the fWT control slices.
Remarkably,LeprcKOexhibitedamuchgreaterLFS-induced
LTD (Figure 5b). Thus, the facilitation of NMDA-induced LTD
in Lepr cKO mice is likely mediated by an increase in
extrasynaptic NMDAR activity. Because extrasynaptic NMDA
receptors contain mostly GluN2B subunits,
70 we therefore
examined the role of GluN2B in LFS-induced LTD. The
application of the GluN2B antagonist ifenprodil completely
blocked LTD in Lepr cKO mice induced by LFS in the
presence of PDC (Figure 5c).
Behavioral responses of Lepr cKO mice to leptin and an
GluN2B antagonist. To determine whether Lepr in forebrain
glutamatergic neurons mediates the antidepressant-like effects
of leptin, we tested the behavioral responses of Lepr cKO mice
to leptin. As described previously,
21 mice received injection of
leptin (1.0mgkg
–1, intraperitoneal) or saline and subjected to
the tail suspension test or forced swim test at 30min after
intraperitoneal injection. ANOVA showed signiﬁcant effects
of genotype (F(1,44)¼18.000; Po0.001), drug treatment
(F(2,44)¼28.811; Po0.001) and interaction between genotype
and drug treatment (F(2,44)¼12.653; Po0.001) on tail
suspension test. Similar results were found in forced swim
test as signiﬁcant effects of genotype (F(1,51)¼8.181;
Po0.01), drug treatment (F(2,51)¼18.277; Po0.001) and
interaction between genotype and drug treatment (F(2,51)¼
3.383; Po0.05). Post hoc analysis demonstrated that Lepr
cKO mice treated with saline exhibited increased immobility
compared with fWT littermate control mice treated with saline
in both behavioral tests (Figures 6a and b). Although leptin
Figure 4 Long-term potentiation (LTP) and long-term depression (LTD) in adult Lepr cKO mice. (a) LTP was induced by a single tetanus (1s per 100Hz) in CA1 of acute
hippocampalslicesfromLeprcKOandlittermate-matchedfWTcontrolmice.LTPiscomparableinhippocampalslicesfromLeprcKOandlittermate-matchedfWTcontrolmice
(open and closed circles, respectively). Examples of ﬁeld excitatory postsynaptic potential (fEPSP) recordings before (green lines) and 60min after LTP (a1) induction (red
lines) are shown in the upper panels. (b) LTD was absent in both Lepr cKO and fWT mice with the stimulation of a single train of 900 pulses at 1Hz. Examples of fEPSP
recordings before (green lines) and 60min after LTD (b1) induction (red lines) are shown in the upper panels. (c) Input–output curves with the postsynaptic response (initial
slope of fEPSP) plotted as a function of the presynaptic ﬁber volley amplitude is indistinguishable between Lepr cKO mice and fWT control mice. (d) Paired-pulse facilitation
(PPF)isvirtuallyidenticalforLeprcKOandfWTcontrolmiceoverthewholerangeofinterstimulusintervals.Dataarepresentedasmean±s.e.m.Thegroupsizesaregivenin
each graph.
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Translational Psychiatrysigniﬁcantly decreased ‘behavioral despair’ in fWT littermate
controls, this effect was abolished by deletion of Lepr in
forebrain glutamatergic neurons in Lepr cKO mice (Figures 6a
and b).
Selective GluN2B antagonists produce antidepressant
actions similar to ketamine in both animal models and
humans.
14,20 We examined whether Lepr cKO mice respond
to antidepressant effects induced by blocking GluN2B. Mice
were administered the selective GluN2B antagonist Ro25-
6981 (3.0mgkg
–1, intraperitoneal) and tested as described
above. Post hoc analysis demonstrated that Ro25-6981
treatment induced a greater reduction of ‘behavioral despair’
Figure 5 The N-methyl-D-aspartate (NMDA)-induced long-term depression (LTD) is facilitated in adult Lepr cKO mice. (a) LTD induced with bath application of 20mM
NMDA for 7min is signiﬁcantly increased in Lepr cKO mice compared with fWT mice (open and closed circles, respectively, Po0.005). Examples of ﬁeld excitatory
postsynaptic potential(fEPSP) recordingsbefore (green lines) and60min after LTDinduction (red lines) are shown in panel a1.( b) LTD inducedby thestimulation of a single
train of 900 pulses at 1Hz with bath application of 300mM L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC) is signiﬁcantly increased in Lepr cKO mice compared with fWT
mice (open and closed circles, respectively, Po0.01). Examples of fEPSP recordings before (green lines) and 60min after LTD induction (red lines) are shown in panel b1.
(c)LTDinducedbythestimulationofasingletrainof900pulsesat1Hzwithbathapplicationof300mML-trans-2,4-PDCiscompletelyblockedbyGluN2Bantagonistifenprodil
inLeprKOmicecomparedwithfWTmice(98±5vs100±4%at70–75min,openandclosedcircles,respectively).Dataarepresentedasmean±s.e.m.Thegroupsizesare
given in each graph.
Figure 6 Behavioral responses of Lepr cKO mice to leptin and GluN2B antagonist. (a) Tail suspension test. Leptin (1mgkg
–1), selective GluN2B antagonist Ro25-6981
(3mgkg
–1)orsalinewereintraperitoneally(i.p.)administeredtomice30minbeforethetest.Immobilitytimewasmeasuredduringthe6-mintestperiod.Dataarepresentedas
mean±s.e.m; n¼8–9 per group.
#Po0.05 compared with saline-treated fWT group, **Po0.01, ***Po0.001 compared with saline treatment within the same genotype.
(b) Forced swim test. Mice were treated as described in panel a. Immobility time was measured during the last 4min of the 6-min test period. Data are presented as
mean±s.e.m; n¼7–13 per group.
#Po0.05 compared with saline-treated fWT group, **Po0.01, ***Po0.001 compared with saline treatment within the same genotype.
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Translational Psychiatryin Lepr cKO mice than fWT littermate controls in the tail
suspension test (71% for Lepr cKO mice versus 46% for fWT
littermate controls), eliminating the difference in ‘behavioral
despair’ between the two genotypes (Figure 6a). Similar
ﬁndings were obtained from the forced swim test (63%
decrease in immobility for Lepr cKO mice versus 42% for
fWTlittermatecontrols;Figure6b).Theseresultssuggestthat
Ro25-6981 can reverse the increased ‘behavioral despair’ in
depressive Lepr cKO mice. Together, these ﬁndings suggest
that the leptin receptor on forebrain glutamatergic neurons is
required for the antidepressant-like behavioral effect of leptin,
and the GluN2B antagonist has antidepressant efﬁcacy in
mice resistant to leptin.
Discussion
There are several interesting ﬁndings in this study. First,
selective ablation of the long form of Lepr in forebrain
glutamatergic neurons located in the hippocampus and dorsal
cerebral cortex leads to depression-related behaviors. Sec-
ond, NMDA-induced hippocampal LTD is facilitated in mice
lacking Lepr in forebrain glutamatergic neurons, which is
mediated by GluN2B-containing NMDA receptors. Third,
these mice are sensitive to the antidepressant-like behavioral
effects of the GluN2B antagonist but resistant to leptin. These
ﬁndings provide strong evidence for a critical role of Lepr
signaling in forebrain glutamatergic neurons in regulating
depression-related behaviors and suggest a functional
relationship between Lepr signaling and NMDA receptors in
modulating depression-related behaviors and induction of
long-term synaptic depression.
Depressionisacomplexdisordercharacterizedbycomplex
patterns of symptoms. We assessed behavioral phenotypes
of Lepr cKO mice using a battery of tests that detect different
aspects of depression, including anhedonia, behavioral
despair, learned helplessness and social withdrawal. Under
basal conditions, loss of Lepr in forebrain glutamatergic
neurons caused an anhedonia-like phenotype in the sucrose/
saccharin preference tests. Also, Lepr cKO mice displayed
behavioral despair in the tail suspension and forced swim
tests. Stress is a key environmental factor that can trigger the
onset of depression in genetically vulnerable individuals.
Increased susceptibility to stress-induced depressive behav-
iors was observed in Lepr cKO mice as evidenced by
increased escape latency and number of failures to escape
following exposure to inescapable foot shock and enhanced
social avoidance after exposure to chronic social defeat.
These ﬁndings suggest that defects in Lepr signaling in
forebrain glutamatergic neurons may be a predisposition that
interacts with stress to increase vulnerability for depression.
Locomotor activity and visual functions were not affected in
Lepr cKO mice, suggesting that the depression-like behav-
ioral deﬁcits in these mice cannot be attributed to motor or
sensory impairments. We have previously shown that leptin
producesantidepressant-likeeffectsinratsandmice,
21,22and
this ﬁnding has been recently conﬁrmed by another research
group.
23 However, it remained unclear what neuronal
populations mediate leptin’s antidepressant-like effects.
In the present study, we demonstrated that loss of Lepr in
glutamatergic neurons in the hippocampus and cortex
abolished the antidepressant-like behavioral effect of leptin
in both the forced swim test and the tail suspension test.
These results suggest that glutamatergic neurons in the
dorsal forebrain regions are targets for leptin’s action on
depressive-like behaviors. Although depression often coex-
ists with anxiety, there were no evident signs of anxiety
observedinLeprcKOmiceasassessedinmultiplebehavioral
testsincludingtheEPM,light/darkchoiceandopen-ﬁeldtests.
Our recent studies have shown that mice with selective
ablation of Lepr in midbrain dopamine neurons display
anxiogenic-like behaviors without affecting depression-like
behaviors.
45 Taken together, these ﬁndings suggest that
leptin actionon depression-and anxiety-relatedbehaviors are
mediated by distinct neuronal circuits.
Increasingevidencepointstoalinkbetweenimpairmentsof
plasticity at glutamatergic synapses and depression. LTP and
LTD are two major forms ofpersistent synaptic plasticity in the
central nervous system characterized by a long-lasting
increase or decrease in synaptic strength, respectively.
Stress, including chronic unpredictable stress, an animal
model of depression, has been shown to impair LTP and
facilitateLTDintheadulthippocampus,
61,71–73andtheeffects
of stress on synaptic plasticity can be blocked by treatment
with antidepressants.
61,74 Previous pharmacological studies
have reported that leptin regulates hippocampal long-term
synaptic plasticity. However, the results from these studies
are inconsistent. Both enhancement and inhibition of hippo-
campal LTP in response to leptin treatment have been
reported,
75–77 often depending on the dosage of leptin used
or the age of animals. In mice and rats with naturally occurring
loss-of-function mutations in Lepr (db/db, fa/fa), both LTP and
LTD are impaired.
78–80 However, these animals are morbidly
obese and diabetic with hyperinsulinemia and hypercorticos-
teronemia.
81–83 Both insulin and corticosterone have been
shown to modulate LTP and LTD.
84–90 Thus, one cannot rule
out the possibility that abnormally high levels of insulin and
corticosteronecontributetothedisruptedLTPandLTDinduction
observed in db/db mice and fa/fa rats. In this study, mice with
ablation of Lepr selectively in forebrain glutamatergic neurons
hadnormalbodyweightandnormalinsulinandcorticosterone
levels. Standard electric stimulus-induced LTP or LTD was
not affected in these mice, but they displayed a robust
enhancement of chemically (NMDA)-induced LTD in adult
hippocampus. This could result from a deﬁcit in the develop-
mental switch from GluN2B- to GluN2A-containing receptors
at synapses. However, this possibility is not supported by the
datapresentedhereassynapticNMDARactivityandGluN2B/
GluN2A ratio were not signiﬁcantly elevated at the synapses
of Lepr cKO mice. Another possibility is that increased
extrasynaptic NMDAR activity causes LTD in Lepr cKO mice.
Inhibiting the synaptic glutamate transporter facilitates
spillover of glutamate to extrasynaptic sites. We found that
the treatment with PDC, a glutamate transporter inhibitor,
dramatically increased low-frequency electrical stimulation-
induced LTD in Lepr cKO mice. Thus, activation of extra-
synaptic NMDA receptors by glutamate spillover in Lepr cKO
mice is likely responsible for the induction of LTD. NMDA
receptor GluN2B subunits are localized predominantly at
extrasynaptic sites.
70 We found that selective blockade of
NMDA receptors containing the GluN2B subunit by ifen-
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facilitation of LTD induction in Lepr cKO requires GluN2B,
possibly by elevating expression or signaling of extrasy-
naptic GluN2B.
NMDA receptor antagonists, such as ketamine, exert rapid
and robust antidepressant effects in some patients with major
depression.
6,17,18 Selective GluN2B antagonists have been
usedtotreatpatientswithtreatment-resistantdepression.
20In
animal studies, the nonselective NMDA antagonist ketamine
and the GluN2B-speciﬁc antagonist Ro25-6981 have been
shown to reverse behavioral despair and learned helpless-
ness.
12,14 In this study, we demonstrated that Lepr cKO mice
were highly sensitive to the antidepressant-like behavioral
effects of the GluN2B antagonist Ro25-6981 in both the tail
suspension test and the forced swim test, whereas leptin
failed to show the antidepressant-like behavioral effects in
these mutant mice. These ﬁndings suggest that glutamatergic
neurons in the forebrain region are target neurons mediating
the antidepressant-like effect of leptin and that GluN2B
signaling lies downstream of Lepr signaling in regulating
depression-related behaviors. The reversal of hippocampal
LTD induction and behavioral despair by GluN2B antagonists
in Lepr cKO mice imply a link between induction of persistent
synaptic depression and behavioral manifestation of depres-
sion. However, further investigations are required to better
understand this association. Whether a blockade of a speciﬁc
form of synaptic plasticity could prevent or reverse behavioral
depression remains to be determined. It is noteworthy to point
out that although LTD has been implicated in hippocampus-
dependent learning and memory,
91–95 Lepr cKO mice
exhibited normal performance in hippocampus-dependent
learning and memory tests including spatial and reversal
learning in the Morris water maze, T-maze alternation and
contextual fear conditioning (data not shown).
Recentepidemiologicalstudiesindicatethatobesity,astate
reﬂecting leptin resistance in most obese subjects, increases
the incidence of depression.
96–100 Diet-induced obese mice
display depression-like behaviors
23,101 and are resistant to
antidepressant-like behavioral effects of leptin.
23 However,
the question remains whether depression in obese individuals
occurs secondary to metabolic changes or as a direct con-
sequence of leptin resistance in the limbic circuitry. Although
global loss or neuron-speciﬁc loss of leptin signaling (defects
in leptin or its receptor) in mice and humans leads to severe
obesity,
83,102–110 ablation of Lepr in forebrain glutamatergic
neurons had no effect on body weight, adiposity and hormone
levels under basal chow-fed conditions. Thus, the develop-
ment of depression-like behaviors observed in Lepr cKO mice
reﬂects a direct effect of resistance to leptin’s action. Recent
studies have suggested a U-shaped trend in the association
between depression and body mass; both underweight and
obesity are associated with depression.
111–113 We speculate
that low leptin levels in underweight individuals and leptin
resistance in obese people may contribute to the high
prevalence of depression among these populations.
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